Elevated concentrations of antiestrogen binding sites in membrane fractions of human ovarian tumors

被引:5
作者
Batra, S
Iosif, CS
机构
[1] Dept. of Obstetrics and Gynecology, University of Lund
关键词
D O I
10.1006/gyno.1996.0030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The density and affinity of tamoxifen (TAM) binding sites in isolated plasma membrane fractions from human ovarian tissue and ovarian tumors was measured. TAM binding in both membrane preparations was specific, saturable, and had a high affinity (K-D < 1 nM). The density of TAM binding sites in the tumors was at least three times higher than that in the normal ovaries, whereas the affinity of TAM binding sites in the tumors was lower than in normal ovaries. The relatively large number of TAM binding sites that are distinct from estrogen receptors in ovarian tumors suggest that TAM alone and in combination with other chemotherapy could be used with advantage in ovarian cancer. (C) 1996 Academic Press, Inc.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 23 条
[1]   INTERACTION OF ANTIESTROGENS WITH BINDING-SITES FOR MUSCARINIC CHOLINERGIC DRUGS AND CALCIUM-CHANNEL BLOCKERS IN CELL-MEMBRANES [J].
BATRA, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (04) :310-312
[2]   IDENTIFICATION AND CHARACTERIZATION OF MUSCARINIC CHOLINERGIC RECEPTORS IN THE HUMAN URINARY-BLADDER AND PAROTID-GLAND [J].
BATRA, S ;
BJORKLUND, A ;
HEDLUND, H ;
ANDERSSON, KE .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1987, 20 (02) :129-135
[3]   CHARACTERIZATION OF MUSCARINIC CHOLINERGIC RECEPTORS IN HUMAN OVARIES, OVARIAN-TUMORS AND TUMOR-CELL LINES [J].
BATRA, S ;
POPPER, LD ;
IOSIF, CS .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) :1302-1306
[4]   THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE [J].
BRANDES, LJ ;
BOGDANOVIC, RP ;
CAWKER, MD ;
BOSE, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) :21-23
[5]   EFFECT OF ENDOCRINE THERAPY ON GROWTH OF T61 HUMAN BREAST-CANCER XENOGRAFTS IS DIRECTLY CORRELATED TO A SPECIFIC DOWN-REGULATION OF INSULIN-LIKE GROWTH FACTOR-II (IGF-II) [J].
BRUNNER, N ;
YEE, D ;
KERN, FG ;
SPANGTHOMSEN, M ;
LIPPMAN, ME ;
CULLEN, KJ .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) :562-569
[6]   TRIPHENYLETHYLENE ANTIESTROGEN BINDING-SITES (TABS) SPECIFICITY [J].
CLARK, JH ;
MITCHELL, WC ;
GUTHRIE, SC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (04) :433-437
[7]   ANTI-ESTROGEN SPECIFIC, HIGH-AFFINITY SATURABLE BINDING-SITES IN RAT UTERINE CYTOSOL [J].
FAYE, JC ;
LASSERRE, B ;
BAYARD, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 93 (04) :1225-1231
[8]   INHIBITION OF PROTEIN-KINASE-C MEDIATED SIGNAL TRANSDUCTION BY TAMOXIFEN - IMPORTANCE FOR ANTITUMOR-ACTIVITY [J].
HORGAN, K ;
COOKE, E ;
HALLETT, MB ;
MANSEL, RE .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) :4463-4465
[9]   DIFFERENTIAL MODULATION OF DOXORUBICIN TOXICITY TO MULTIDRUG AND INTRINSICALLY DRUG-RESISTANT CELL-LINES BY ANTIESTROGENS AND THEIR MAJOR METABOLITES [J].
KIRK, J ;
HOULBROOK, S ;
STUART, NSA ;
STRATFORD, IJ ;
HARRIS, AL ;
CARMICHAEL, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1189-1195
[10]   EVIDENCE THAT TAMOXIFEN IS A HISTAMINE ANTAGONIST [J].
KROEGER, EA ;
BRANDES, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (02) :750-755